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Opioids have been viewed for centuries as the most effective treatment for 
chronic pain, yet in the past decade the misuse of prescription opioids has become a 
substantial problem in the United States (Brucker, 2008; Compton & Volkow, 2006; 
Denisco, Chandler, & Compton, 2008; Rosenblum, Marsch, Joseph, & Portenoy, 2008).  
According to a document published by the Office of National Drug Control Policy,    
The number of prescriptions filled for opioid pain relievers—some of the most 
powerful medications available—has increased dramatically in recent years. From 
1997 to 2007, the milligram per person use of prescription opioids in the U.S. 
increased from 74 milligrams to 369 milligrams, an increase of 402 percent.  In 
addition, in 2000, retail pharmacies dispensed 174 million prescriptions for 
opioids; by 2009, 257 million prescriptions were dispensed, an increase of 48 
percent (Office of National Drug Control Policy (ONDCP), 2011, p.1).     
  According to the results from the 2010 National Survey on Drug Use and Health 
(NSDUH) (Substance Abuse and Mental Health Services Administration (SAMHSA), 
2011), 17.3% reported pain relievers as the initial drug of illicit drug use.  In addition, the 
non-medical use of prescription pain relievers is the second most common form of illicit 
drug use (Compton & Volkow, 2006; SAMHSA, 2009a).  Additionally, another NSDUH 
report, an estimated 5.2 million people had reported non-medical prescription opioid 
misuse (SAMHSA, 2009b).  On the other hand, according to the Treatment Episode Data 
Set (TEDS), a mere 7.1% of individuals that were admitted into a substance abuse 
treatment facility report other opioids as his or her primary substance of abuse 




(SAMHSA, 2009b).  Moreover, these statistics indicate that although a substantial 
number of individuals report non-medical prescription opioid misuse, only a small 
percentage are undergoing the necessary treatment.   
The Center for Disease Control and Prevention (CDC) (2010), provided statistics 
stating prescription opioid misuse overdose incidents have been increasingly surpassing 
those individuals overdosing from heroin by approximately 5.38 times. (See Figure 1)  In 
addition, the lack of individuals receiving substance abuse treatment has facilitated a 
need to address prescription opioid misuse in individuals with non-malignant chronic 
pain through the implementation from a multidisplinary team approach with the purpose 
of providing the adequate education to consumers for this widespread epidemic (ONDCP, 
2011).   
Figure 1.  
 
Background of the Problem 




The Egyptians described the medicinal purposes of opioids dating back as early as 
1500 BC (Meyer & Quenzer, 2005).  Opioid can be defined as relating to any synthetic or 
natural action to that of morphine, which is derived from opium (Hanson, Venturelli, & 
Fleckenstein, 2006; Meyer & Quenzer, 2005).  Opioids are most commonly used to have 
effects on the central nervous system and the gastrointestinal tract, but can also be used as 
a cough suppressant (Hanson et al., 2006; Meyer & Quenzer, 2005).  In the human body 
there are three classes of opioid receptors that directly interact with the brain, spinal cord, 
and gastrointestinal tract with the control of the endogenous opioid peptides (Hanson et 
al., 2006; Lehne, 2007; Meyer & Quenzer, 2005).  Endogenous opioid peptides are small 
proteins that when released send a message to the brain, spinal cord, and gastrointestinal 
tract that alters the bodies perception of pain (Hanson et al., 2006).  Much of the effects 
of the opioid depend on the pharmacokinetics and the pharmacodynamics of the specific 
opioid (Meyer & Quenzer, 2005; Morgan, Frost-Pineda, & Gold, 2006).  For instance, if 
the opioid is administered intravenously at a higher dose, the individual may experience a 
higher level of euphoria than would an individual who ingested a lower dose (Meyer & 
Quenzer, 2005).  Some of the most common types of opioids are morphine, oxycodone, 
hydromorphone, hydrocodone, methadone, and fentanyl.  In addition, some of the less 
potent forms of opioids are codeine, meperidine, pentazocine, and propoxyphene 
(Morgan et al., 2006).            
Pain can be viewed as if it is on a continuum in the fact that it affects people 
according to the individual perception; therefore, can be difficult to objectively measure 
(Modesto-Lowe, Johnson, & Petry, 2007).  Pain tends to be measured according to a self-
reported rating of pain intensity from 0 to 10, with 0 being no pain and 10 being the most 




intense pain.  Again, the ambiguity of whether an individual is being truthful lies within 
the primary care provider’s professional judgment, along with the facts of point of 
reference in which the pain is a response to.  In other words, if an individual with a 
physical disability sees the doctor, the primary care provider may be more apt to 
prescribe an opioid, as opposed to an individual with inflammatory pain, which has 
shown to be non-responsive in these consumers (Walwyn, Miotto, & Evans, 2010).   
Although those who have received opioids for acute pain have a lower probability 
for addiction, long-term administration of opioids for chronic pain has been linked to 
prescription opioid misuse (Comptom & Volkow, 2006).  The ability for an individual to 
obtain analgesic opioids has become increasingly accessible (Cicero et al., 2007).  Most 
individuals obtain prescription from the family physician.  Other times individuals obtain 
these medications from others who have been prescribed, but perhaps did not follow the 
recommended dose and had excess.  Analgesic opioids can usually be found in homes of 
family and friends (Mendelson, Flower, Pletcher, & Galloway, 2008).  According to the 
NSDUH report, 55.7% of individuals that misused prescription opioids said reported they 
obtained them from a family member or a friend for free, while 11.4% purchased the 
opioid from family or a friend (SAMHSA, 2011).   
Whether from a family member or friend, any individual taking a prescription that 
was neither prescribed to them nor an intended dosage is misusing prescription opioids.  
Taking more than the prescribed recommended dosage is also considered prescription 
opioid misuse.  In addition, some individuals misuse the opioid by diverting from the 
intended route of administration (Cicero et al., 2007; Morgan et al., 2006).  For instance, 
a consumer prescribed an oral dose of an opioid that instead crushes the pill for nasal 




ingestion has altered the intended route of administration; therefore, misusing.  
Additionally, alternate forms of aberrant behaviors are known as “doctor shopping” and 
“pharmacist shopping” (DuPont, 2010; El-Aneed et al., 2009).  Inevitable these are 
people that are seeking multiple primary care providers or utilizing multiple medication 
dispensaries to obtain the desired opioid prescription, yet are still consider misuse 
regardless.    
People tend to have an attitude towards opioids that these drugs are “safer” than 
illicit drugs because they are normally prescribed by a physician, yet are completely 
unaware of the potential dangerous side-effects (Bryne, Lander, & Ferris, 2009).  
SAMHSA Drug Abuse Warning Network (DAWN) report indicated that the emergency 
room visits for the non-medical use of opioid analgesic increased 111% from 2004 to 
2008 (CDC, 2010).  More and more individuals are seeking services from emergencies 
rooms because he or she has non-medically misused analgesics opioid (Mendelson et. al, 
2008).  As mentioned previously, the rate of unintentional prescription opioid overdoses 
have been steadily increasing since 2001 (CDC, 2010). 
Attempting to maintain optimal quality of life while experiencing chronic pain 
can be a difficult task to manage.  Individuals with opioid abuse and/or dependence are 
more likely to have a decrease in productivity in the workplace, accounting for a loss of 
60 billion dollars a year (Passik & Kirsh, 2008).  According to Hardan (2008), consumers 
being prescribed opioids for pain management are at an increased rate of unemployment, 
compared to individuals using non-pharmacological treatments.  If there is an opioid 
dependence, the consumer may be unemployed because of the concern regarding where 
to obtain the next pain reliever.  In addition, transportation barriers are substantial in 




individuals who have opioid abuse and/or dependence for the consumer is less likely to 
be able to operate a vehicle or find employment, let alone seek substance abuse treatment 
(Brucker, 2008). 
Significance of the Study 
The fact still remains that there is an unclear division between who should and 
should not be prescribed prescription opioids.  According to research originally from 
Pasero (2007), “Untreated pain can exacerbate underlying medical conditions, decrease 
activity and conditioning decrease productivity, delay rehabilitation, and increase 
emotional distress causing psychological symptoms, sleep deprivation, and inability to 
manage daily activities” (Walwyn et al., 2010, p. 157).  Individuals must also be able to 
utilize the medicinal effects of opioids, if deemed appropriate to optimize quality of life 
(Wilsey, Fishman, Casamalhuapa, & Gupta, 2009).   
On the other hand, problems amongst the medical community in treating 
individuals with chronic pain arise due to the controversy associated with pain 
management (Butler et. al., 2007; Mendelson et. al, 2008; Naliboff, Wu, & Pham, 2006; 
Walwyn et. al., 2010).  Some report that primary care providers over prescribe opioid 
medication to consumers with chronic pain, whereas others report that the under 
prescribing of opioids contributes to prescription opioid misuse to some individuals 
seeking pharmacological treatment (Adams et al., 2004; Gallagher & Rosenthal, 2008; 
Holmes et al., 2006; Modesto-Lowe et al., 2007).  Individuals are entitled to use 
medication as a form of pain relief; however, consumers appear to have a lack of 
understanding regarding the abuse and dependence potential.  Moreover, could there be a 
potential shift in the number of individuals receiving prescription opioids from pain 




management specialists, or has the insurances companies shifted consumers in a direction 
that primary care provider provides pain management resulting in the increase of 
prescription opioid misuse? (Morgan et al., 2006).    
Medical professionals may not necessary have the adequate knowledge of the 
substance abuse and dependence potential opioids have (Buelow, Haggard, & Gatchel, 
2009).  Clarification of the of substance abuse and dependence is essential for the 
purpose of this paper and will be defined in accordance to the Diagnostic and Statistics 
Manual-Forth Edition (DSM-IV) criteria.  The DSM-IV criterion defines abuse and 
dependence as separate entities.  A consumer meeting criteria for abuse may tend to have 
difficulty fulfilling his or her role in the family, work, or school which may also lead to 
interpersonal problems.  Although these individuals are not experiencing opioid 
withdrawal symptoms, the consumer’s actions are usually associated with legal 
consequences as a result of behavior or the method of which the opioid was obtained.   
Opioid dependence is likely to be associated with higher levels of tolerance and 
experiencing significant withdrawal symptoms.  Mainly individuals with opioid 
dependence are spending a greater part of their day obtaining the opioids or using them in 
a manner in which they were not intended.  According to Densico et al. (2008), 
individuals receiving pain management treatment currently fall into the DSM-IV 
diagnostic criteria for opioids dependence disorder, as these individuals have met 
criterion for tolerance and withdrawal.  Of course not every individual prescribed an 
opioid will develop an opioid use disorder, but the medical professionals need to be 
cognizant of the potential and how to determine abuse and dependence in accordance to 
the DSM-IV criteria.  




Medical professionals not only need to be aware of the fact that prescription 
opioid abuse exists in chronic pain consumers and is prevalent in today’s society, but the 
affect it could bring in terms of difficulty with obtaining treatment.  If medical 
professionals continue to prescribe opioids without appropriate screening, the rate of 
misuse will continue to increase and the consumers likely to seek treatment will decrease.  
According to the 2007 TEDS, 51.6% of individuals admitted themselves for other opioid 
as his or her primary substance of choice, whereas the next highest percentage (16.6%) 
were referred to treatment via the criminal justice system (SAMHSA, 2009b).  Moreover, 
aside from an individual, personally seeking the treatment he or she needs, other avenues 
need to be explored to determine the most efficient and effective method to refer 
consumers with prescription opioid misuse to treatment.      
Summary of Chapter 1 
Opioids have been found to be an effective treatment modality for individuals 
with chronic pain, yet the number of prescription opioids filled from 1997 through 2007, 
increased 402 percent (ONDCP, 2011).  With the increase of number of prescriptions 
being filled, there has been an increase in the number of individuals misusing prescription 
opioids.  Society appears to be unaware of the abuse and dependence potential opioids 
have.  Additionally, some medical professionals tend to lack the necessary knowledge 
when providing pharmacological treatment to individuals with chronic pain.  The long-
term administration of opioid therapy in individuals with chronic pain has been found to 
be linked to prescription opioid use.  In addition, research suggests that the number of 
individuals seeking treatment for prescription opioid misuse as the primary substance is 
quite low in comparison to the number of individuals reporting prescription opioid 




misuse.  These facts solidify the need to further examine prescription opioid misuse 
specifically with individuals experiencing non-malignant chronic pain.   
Purpose and Objectives of the Paper 
The purpose of this paper is to justify the need for a multidimensional approach 
from medical professionals providing services to consumers with non-malignant chronic 
pain while utilizing an effective screening instrument when assessing pharmacological 
opioid treatment for pain management.  Screening consumers with chronic pain for abuse 
potential could aide in future identification and potential prevention of prescription 
opioid misuse.  A further review of the literature regarding potential factors that 
contribute to the misuse of prescription opioids, along with examination of current 
screening instruments and monitoring programs will be discussed.  In addition, a 
synthesis of the literature followed by future implications, recommendations for 
Rehabilitation Counselors, and conclusions.  
Definition of Terms 
Prescription opioid misuse: A term used interchangeably with non-medical prescription 
analgesic use (NMPAU) that is the use of an opioid in a manner other than it was 
prescribed. 
 
Primary care provider: any medical professional trained and certified to prescribe 
medications. (ie. physicians, dentists, psychiatrists, and nurse practitioner) 
 
SAMHSA-Substance Abuse and Mental Health Service Administration: A federal agency 
that was developed to improve upon prevention and treatment for substance abuse and/or 
dependence, and mental health services. 
DSM-IV-Diagnostic and Statistics Manual: Published by the American Psychological 
Association (APA), this manual is a standard classification for all mental disorders. 
 
SUD-Substance Use Disorder: A disorder in the DSM-IV that is characterized by abuse 
or dependence, depending on the severity of the substance use. 
 




PWD-Persons with a disability: Any person who has a physical or mental impairment 
that substantially limits one or more major life activities, that has a record of such 
impairment, or is regarded as having such an impairment.   
 
PMQ-Pain Management Questionnaire: A self-reported screening instrument that is used 
to assess potential opioid misuse in individuals experiencing pain. 
 
POMI-Prescription Opioid Misuse Index: An interview based screening instrument that 
is use to assess potential aberrant drug-seeking behaviors. 
 
SOAPP-Screener and Opioid Assessment for Patients with Pain: A brief screening 
instrument to assess potential opioid misuse in individuals seeking long-term opioid 
therapy.   
 
PODS-Prescription Opioid Documentation and Surveillance System: A computer based 
survey instrument used to help primary care providers when determine opioid therapy 
appropriateness.  
 
COMM-Current Opioid Misuse Measure: A screening instrument used to assess current 
aberrant drug-seeking behaviors in individuals currently undergoing opioid therapy. 
 
PMP-Electronic Prescription Monitoring Program: A monitoring program was the 
implemented as a means for primary care providers and law enforcement agencies to 
monitor abuse and diversion.   
 
RADARS-Research Abuse, Diversion, and Addiction Related Surveillance: A risk 
management program developed to detect abuse and diversion of opioids within a certain 
geographically region.  
 
 





OVERVIEW OF LITERATURE 
Characteristics 
The current literature in discussion examined characteristics associated with 
prescription opioid misuse in individuals with chronic pain.  A study conducted by 
Cicero, Lynskey, Todorov, Inciardi, and Surratt (2008) sought to determine if chronic 
pain was a factor in prescription opioid misuse and if early substance use is a precursor 
for opioid misuse.  The researchers found that 60 % of individuals who were non-
medically misusing opioids reported moderate to severe chronic pain and reported a low 
quality of life.  In addition, 45% reported misusing opioids solely due to his or her pain, 
whereas only 14% used opioids for the first time “to get high”.  Specifically, between 60-
70% of the participants reported continuing the use of opioids even after his or her pain 
had subsided.  In this study, early exposure to substances had a significant impact on the 
individual’s psychopathology.  Females represented the majority of individuals whose 
first time use was for pain management, while males tended to use for the euphoria 
effects.  Moreover, this study has recognized that any service provider working with 
individuals with chronic pain need to remember the impact opioids could potentially have 
on the consumer (Cicero, Lynskey, Todorov, Inciardi, & Surratt, 2008).   
Consistent with the above study, Becker et al. (2009) performed a study to 
determine if a relationship exists between chronic pain and prescription drug abuse.  
More specifically, this study used Veteran participants whom were referred for a 
behavioral health evaluation from the primary care provider.  The results yielded an 
independent correlation between chronic pain and prescription drug abuse.  Furthermore, 




the researchers found that those misusing prescription opioid are “younger age, being 
unmarried, having a strained financial situation, possible and probable depression, current 
smoking, past year illicit drug use, and chronic pain were all 
associated with any prescription drug abuse” (Becker et al., 2009, p.533).   In addition, 
results were consistent with that of previous empirical data and found that individuals 
who were younger and had used illicit drugs previously, or had a mental illness were at 
higher risk for prescription drug abuse (Becker et al., 2009). 
Additionally another study, conducted by Ives et al. (2006) utilized a 
multidisciplinary approach when managing participants that consisted of “ a clinical 
pharmacist practitioner, an internist, a psychiatrist with sub-specialization in pain 
medicine, a nurse, and a program assistant” (p.1) when assessing for potential risk factors 
associated with prescription opioid misuse.  Unlike the previous mentioned study, the 
researchers did not find a consistent correlation between pain and prescription opioid 
misuse.  On the other hand, the most prominent factors linked to non-medical 
prescription opioid misuse was self-reported history of alcohol or cocaine abuse along 
with previous drug or alcohol-related convictions.  Moreover, the researchers suggest that 
the study population appears to be more likely to have co-occurring disabilities.  
Additionally, those with co-occurring substance use disorders (SUD) are at a higher risk 
for morbidity and mortality.  Furthermore, the researchers justified a need to minimize 
the risk associated with non-medical prescription opioid misuse, while also maximizing 
chronic pain management (Ives et al., 2006).  
Novak, Herman-Stahl, Flannery and Zimmerman (2009) conducted a study to 
determine if there is a correlation between physical pain and non-medical prescription 




analgesic use (NMPAU) utilizing cross-sectional data from the National Epidemiological 
Survey on Alcohol and Related Conditions (NESARC) and a community based sample. 
The results yielded that there is a positive correlation between levels of pain and NMPAU 
for both individual who do and do not meet DSM-IV criteria.  Results reflected that even 
with the additional factor of substance use and psychiatric disabilities the correlation 
remained consistent; therefore, implying that there is an independent correlation between 
pain and NMPAU.  The researchers also found that prior substance use was a prominent 
factor with NMPAU according to the degree of pain.  On the other hand, the study 
indicated that there is a high prevalence of co-occurring disorders between SUDS and 
psychopathology.  Specifically, there is a distinctive relationship between anxiety 
disorders and those who do not meet DSM-IV criteria.  Meanwhile, there is a similarly 
unique relationship between mood disorders and those that do meet DSM-IV criteria for 
abuse and/or dependence (Novak, Herman-Stahl, Flannery & Zimmerman, 2009).  This 
study is consistent with previous studies mentioned above, yet it provided valuable 
information on co-occurring disorders.     
As the research suggests, individuals misusing prescription opioid appear more 
susceptible to have a SUD and/or mental disability.  With this notion, co-occurring 
disorders rendered a further evaluation to examine whether or not a relationship exists; 
however limited research exists on persons with a disability (PWD).  Brucker (2008) 
conducted a study that involved determining if there is a link between prescription drug 
abuse and persons with a mental disability.  PWD more frequently interact with medical 
professionals; hence, this population appears to be more prone to being prescribed 
opioids with a greater chance of misusing prescription opioids.  Moreover, according to 




Waldrop and Stern (2003), substance abuse by PWD accounts for 53 million individuals 
in the United States (as cited by West, Graham, and Cify, 2009).  The researchers found 
that individuals with a mental disability are significantly more susceptible to have an 
issue with misusing opioids.  Additionally, PWD with primary alcohol, marijuana, or 
cocaine abuse were less likely to have a secondary problem with opioid misuse, which is 
in contrast to previous findings (Brucker, 2008). 
A study proposed by Becker, Sullivan, Tetrault, Desai, and Fiellin (2008) 
assessed clinical characteristics associated with psychopathology and how it relates to 
non-medical use of prescription opioids.  All participants had admitted to past year 
prescription opioid misuse.  The researchers found “that younger age (especially 18–21), 
Hispanic ethnicity, unemployment, panic, depressive and agoraphobic/social phobic 
symptoms, past-year alcohol abuse/dependence, cigarette smoking, other prescription 
drug misuse, other illicit substance use and young age of initiating substance use are 
significantly associated with past-year non-medical use of prescription opioids” (Becker, 
Sullivan, Tetrault, Desai, & Fiellin, 2008, p.41).  Moreover these researchers indicated 
potential risk factors associated with the ever growing problem of prescription opioid 
misuse, consistent with previous research that can help primary care providers identify 
individuals that may be at risk to develop a prescription opioid misuse.  
Another study attempted to better describe the characteristics of individuals and 
the correlation and predictors of the misuse.  Passik, Hays, Eisner, and Kirsh (2006) 
found that 84% of the participants reported that they have received a prescription from a 
physician for pain management at some point, with 61 % reported experiencing chronic 
pain, while all participants reported non-medical misuse of prescriptions.  According to 




the Distress Thermometer, the biggest concern for the participants was pain (76%), while 
55% indicated distress due to anxiety, and 53% was reportedly due to depression.  
Additionally, 91 % had obtained the opioid from a street dealer and 80% changed the 
intended route of administration.  Furthermore, the researchers finding was consistent 
with that of previous studies and indicated that individuals who non-medically misuse 
opioids tend to have co-occurring substance abuse and/or dependence along with a 
psychiatric disability (Passik, Hays, Eisner, & Kirsh, 2006). 
Medical Professionals 
The dilemma occurs most frequently to primary care providers regarding 
treatment modalities for individuals with chronic pain.  The primary care providers are 
essentially in this dilemma due to the inefficient training received in relation to pain 
management and substance abuse or dependence (Wiedemer, Harden, Arntd, & 
Gallagher, 2007).  Wiedemer Harden, Arntd, & Gallagher conducted a study to measure 
the effectiveness of a program implemented at an Opioid Renewal Clinic (ORC) in a 
primary care setting (2007).  Additionally, the researchers consisted of a nurse 
practitioner, clinical pharmacist, and a multidisciplinary team.  The program consisted of 
an opioid treatment agreement that included urine drug testing and other standardized 
documentation.  The results suggest that the use of the ORC model in this study provided 
a decrease in positive urine drug tests and a decrease in aberrant behaviors (Wiedemer et 
al., 2007).  Moreover, this study suggested that primary care providers can manage 
treatment for individuals with chronic pain with appropriate tools while utilizing a 
multidisciplinary team.    




In a study conducted by Gunderson, Levin, and Owen (2008), the researchers 
assessed students in a residency training program when screening for alcohol misuse and 
illicit drug use, by incorporating a two-day training session into the curriculum at a 
substance abuse treatment facility.  The results yielded that the medical residents 
improved in the screening evaluation of consumers in regards to alcohol; however, the 
residents still did not utilize a valid alcohol screening instrument such as the Cut Down, 
Annoyed, Guilty and Eye Opener (CAGE).  On the other hand, the participants were 
more likely to screen for illicit drug use due to the familiarity with the DSM-IV criteria 
during the training program (Gunderson, Levin, & Owen, 2008).  Similarly to the 
previous study, the researchers provide adequate knowledge for the need of training in 
primary care providers when screening for illicit drug use.   
Additionally, Isaacson et al. (2005), reported seven red flag signs that may aid in 
the identification of individuals misusing prescription opioids (As cited by Weigel, 
Donovan, Krug, & Dixon, 2007).  
“These warning signs are (a) demonstrating more concern about obtaining a drug 
than about resolving any medical issues, (b) reporting multiple medication 
sensitivities, (c) stating an inability or unwillingness to take generic medications, 
(d) refusing to participate in diagnostic workups or consultations, € presenting 
with an unusually sophisticated knowledge of drugs, (f) appealing to the physician 
that he or she is the only person who can help, and (g) reporting lost or misplaced 
prescriptions (as cited in Weigel et al., 2007). 




The purpose of these warning signs is to provide primary care providers that have 
experienced little to no training what to look for when evaluated for potential prescription 
opioid misuse. 
Screening 
Although there are several studies that include characteristics associated with 
prescription opioid misuse, there appears to be a need within the medical community to 
receive training associated with the utilization of effective and efficient screening 
instrument when assessing potential or immediate risks factors for prescription opioid 
misuse.   
The first instrument is known as the Pain Medication Questionnaire (PMQ) 
developed by Adams et al. (2004), a 26-item self-reported screening instrument 
measuring for potential opioid misuse in individuals with chronic pain.  Validity was 
measured by comparing the PMQ scores with variables that include “the outset of 
treatment, including measures of substance abuse, psychosocial distress, 
physical/functional ability, and employment status” (Adams et al., 2004, p. 442).  
Moreover, several types of validity were examined and results indicated that the higher 
PMQ scores were usually seen in individuals receiving opioid treatment, reporting more 
psychological distress, and poorer physical functioning that may make these individuals 
more at risk for prescription opioid misuse.  In addition, those who reported 
unemployment status scored higher on the PMQ and demonstrated more attitudes and 
behaviors that could put them at risk for misuse (Adams et al., 2004).   
Similar findings to that of the previous study, Holmes et al. (2006) concluded that 
the higher the PMQ scores, the more likely a participant is at risk to misuse opioids.  In 




addition, the facility is comprised of an “interdisciplinary treatment program that includes 
medical, psychological, psychiatric, and physical therapy components” (Holmes et al., 
2006, p. 76).  The interdisciplinary team approach may have yielded the most captivating 
finding in that as the participants went through the program a decrease in the PMQ scores 
were displayed; therefore, a risk decrease in opioid misuse.  Also noteworthy, 
demographically speaking, the results indicate that individuals receiving disability 
funding services were more likely to misuse prescription opioids (Holmes et al., 2006). 
Buelow, Haggard, and Gatchel (2009) designed a study as a validation process to 
determining the validity of a condensed version of the PMQ, while also evaluating the 
predicted validity for prescription opioid misuse.  Results yielded similarly to that of 
Holmes et al. (2006) and were consistent with the findings from Adams and colleagues.  
Moreover, the utilization of an interdisciplinary team has shown to have positive effects 
on diminishing the risks associated with prescription opioid misuse (Buelow et al., 2009).   
The Prescription Opioid Misuse Index (POMI) is a screening tool assessing an 
individual based upon an 8-item interview addressing prescription use behaviors.  
Knisely, Wunsch, Cropsey, and Campbell (2008) results indicated that after running 
several analysis, 6-items were deemed necessary in determining which participants were 
using a prescription opioid as it was medically intended, and those individuals at risk for 
prescription opioid misuse.  An important finding this study revealed was that a highly 
correlated response to at least two of the six questions classified an individual with a 
prescription opioid misuse (61.7%) met DSM-IV criteria for opioid abuse or dependence.  
Additionally, out of the number of individuals that were known to have a substance abuse 
or dependence, 100% met the criteria for at risk of misuse.  Moreover, the POMI is said 




to be and efficient and effective screening instrument in identifying individuals who may 
be at risk for prescription opioid misuse (Knisely, Wunsch, Cropsey, & Campbell, 2008).     
The Screener and Opioid Assessment for Patients with Pain (SOAPP) was 
developed as a brief screening instrument to help assess individuals with chronic pain 
considering long-term opioid treatment (Butler, Budman, Fernandez, & Jamison, 2004).  
Butler, Budman, Fernandez, and Jamison (2004) developed this instrument to assess 
aberrant drug behaviors associated with non-medical prescription opioid misuse.  SOAPP 
is a measure that is easily understood by participants and took minimal time to administer 
and produce results.  Researchers evaluated the internal consistency by using an alpha (α) 
Coefficient for the 14 items in the SOAPP prediction score.  The initial SOAPP responses 
were calculated along with the follow-up responses.  Both scores were calculated and 
were consistent yielding an α=.74.  To determine reliability, test-retest was examined 
utilizing a Pearson product moment correlation between the predicted baseline score and 
at a 6-month follow-up.  The result yielded a correlation was 0.71 and indicated that the 
screening method is reliable and valid.  The appropriateness of the instrumental is 
necessary in order to yield valid results and should be used concurrently with medical 
records and any additional health records (Butler et al., 2004).   
Akbik et al. (2006) conducted another examination of the SOAPP, to assess 
further validation of the instrument.  Reliability was consistent with the previous study 
and results indicated an α=0.75.  In addition, the researchers found that after “a combined 
factor analysis of the SOAPP revealed five factors labeled 1) history of substance abuse, 
2) legal problems, 3)craving medication, 4) heavy smoking, and 5) mood swings” (Akbik 
et al., 2006, p.287).  Moreover, the research suggests that this instrument is a mean to use 




when determining potential prescription opioid misuse in individuals with chronic pain 
(Akbik et al., 2006).   
The Prescription Opioid Documentation and Surveillance (PODS) System was 
developed by Wilsey, Fishman, Casamalhuapa, & Gupta (2009) for the purpose of 
meeting “several specific clinical and documentation needs related to assessment, 
education, and tracking of patients undergoing chronic opioid therapy” (p.867).  The 
PODS system is a computer based survey instrument that utilizes several assessments to 
help clinicians determine appropriateness when initiating opioid therapy in individuals 
with chronic pain.  The preliminary research conducted in this study resulted in a 
potential effective and efficient screening instrument to help assist clinicians without any 
face to face contact when determining consumer’s pain management (Wilsey et al., 
2009).    
Another screening instrument, Current Opioid Misuse Measure (COMM), 
measured past thirty days prescription misuse behaviors.  Butler et al. (2007) developed a 
study for the validation of the COMM, assessing participants receiving services from a 
pain management specialist.  Content validity was evaluated through the utilization of a 
panel of experts, specifically pain and addiction specialist, in an analysis of concept 
mapping.  The 40-item questionnaire consisted of seventeen items that results yielded 
reliability and validity in the identification of prescription opioid misuse in consumers 
currently on long-term opioid treatment.  Unlike the SOAPP designed to measure risk 
potential, the COMM assess current behaviors and thoughts regarding the misuse of 
current prescription opioids (Butler et al., 2007).    




In a further evaluation of the COMM, Meltzer et al. (2011) evaluated the 
diagnostic characteristics of the instrument according to the DSM-IV criteria for 
prescription drug use disorder (PDD).  Unlike the study mentioned above, the researchers 
conducted the study on primary care patients with chronic pain.  The findings indicated 
the COMM can differentiate those consumers who meet DSM-IV criteria for PDD, have 
a co-occurring substance use disorder, or no disorder.  Moreover, it can be said that this 
screening instrument can be beneficial for primary care providers as it can be 
administered in approximately ten minutes and has been rendered useful in determining 
consumers who are less likely to participate in prescription opioid misuse (Meltzer et al., 
2011).   
Monitoring 
The Electronic Prescription Monitoring Program (PMP) was developed as a mean 
of balancing pain management and prescription opioid misuse to the extent that it is 
utilized by the medical community (Katz et al., 2008).  PMP is designed to not only track 
individuals seeking multiple opioid prescriptions, but it also detects excessive 
prescription prescribed by a single primary care provider (DuPont, 2010).  According to a 
survey conducted by Katz et al. 18 of 23 currently running PMP administrators responded 
to the study (2008).  In response to whether or not healthcare providers had access to the 
PMP information, analysis concluded that “two programs provided unsolicited data to 
providers (e.g., providing unsolicited threshold reports on those patients who exceed 
predetermined prescription thresholds), nine provided information upon request only, and 
seven programs did not share data with providers” (2008, p. 589).  Moreover, the 
researchers suggested the need for further research in order to validate the relevance in 




engaging medical professionals in the use of PMP to aid in the access to opioid as a pain 
relief while decreasing the number of consumers misusing prescription opioids (Katz et 
al., 2008).     
Barrett and Wilson (2005) conducted a study to survey physicians in order to 
assess their knowledge of the newly implemented PMP and their attitudes towards the 
program.  Astonishing, less than half of the physicians participating in the study had 
heard about the PMP prior to receiving the survey instrument; therefore, these physicians 
were not included in the results.  A mere 11% responded that the implementation of the 
PMP alternated their current practice (Barrett & Wilson, 2005).  Some physicians 
indicated that they did not use the PMP because 40% did not understand how to properly 
obtain the necessary information.  In addition, 25 % did not think the information was 
relevant, whereas 18% did not participate in the PMP due to the fact that they did not like 
how the information could not be received immediately upon request (Barrett & Wilson, 
2005).  The researchers indicated that physicians are concerned as to the role of the 
physician patient relationship.  More specifically, how with the implementation of the 
PMP affect consumers privacy, and what role will law enforcement have in the program 
(Barrett & Wilson, 2005).     
The Researched Abuse, Diversion and Addiction Related Surveillance 
(RADARS) system was established as a risk management program assessing 
geographical abuse and diversion of opioid drugs, mainly OxyContin, in the pursuit of 
preventative measures (Cicero et al., 2007; Katz, Dart, Bailey, Trudeau, Osgood, & 
Paillard, 2011).  Cicero et al. utilized detection systems that consisted of experts in the 
fields of substance misuse and pain management as it relates to prescription opioid 




misuse, information collected from law enforcement agencies regarding diversion of 
prescription opioids, and data was collected from the Poison Control Center in regards to 
intentional prescription opioid misuse (2007).  The researchers found an overlaying 
between each of the three detection systems which appear to indicate that the RADARS 
system has been validated to regionally understanding that  prescription opioid misuse is 
a nationwide problem and can be further evaluated based upon specific regions.  
Furthermore, the utilization of this system could potentially assist in determining more 
regional specific interventions when facing prescription opioid misuse (Cicero et al., 
2007).   
Summary of Chapter 2 
Upon evaluation of the literature, several studies indicated a positive correlation 
between prescription opioid misuse and individuals with chronic pain.  Throughout these 
studies, the researcher’s findings were fairly consistent with one another and reported that 
individuals who are younger, have a past history of alcohol and/or illicit drug use, or have 
a medical disability appear to be prominent factors linked to prescription opioid misuse.  
Moreover, these factors suggest that individuals who have co-occurring disorder are more 
apt to misuse prescription opioids; however, there is a lack of research involving this 
specific population and the misuse of prescription opioids.  The identification of potential 
risk factors associated with prescription opioid misuse could assist primary care providers 
when determining long-term opioid therapy.   
The predicament for primary care providers is determining long-term opioid 
therapy appropriateness for individuals experiencing chronic pain.  Research suggests 
that medical professional do not necessarily receive the required training to work with 




individuals with addictions and/or pain management.  On the other hand, when the 
primary care providers received brief training or guidelines when prescribing, there was a 
decrease in aberrant drug-seeking behaviors.   
In order for medical professionals to be able to adequately determine the 
appropriateness for long-term opioid therapy, they must first utilize a screening 
instrument.  There are several screening instruments available for primary care providers 
prior to the initial prescribing of the opioid.  Many of these instruments assess for 
potential characteristics and aberrant drug-seeking behaviors associated with prescription 
opioid misuse.  Moreover, individuals being prescribed opioids for long-term therapy 
should also be continuously monitored through the utilization of the PMP and RADARS.  





DISCUSSION AND IMPLICATIONS 
 Summary 
Opioids have been viewed as an effective pharmacological treatment for 
individuals experiencing chronic pain, yet there has been a steady increase in prescription 
drug misuse.  This widespread epidemic has brought upon a vast awareness throughout 
the research community.  Meanwhile, research is steadily attempting to provide adequate 
information to medical professionals when faced with controversy surrounding opioids 
(Rosenblum et al., 2008).  Much of the ambiguity lies in determining whether or not an 
individual will benefit from prescription opioids, or if the initial usage may develop into a 
prescription opioid misuse.   
Consistent throughout the literature, chronic pain and prescription opioid misuse 
were found to have a positive correlation (Becker et al., 2009; Cicero et al., 2008; Novak 
et al., 2009).  The correlation between chronic pain and prescription opioid misuse 
solidified the need for a further evaluation of the affiliation between these two concepts.  
In addition, chronic pain and prescription opioid misuse appear to have validated a 
unique concern as Passik et al. found, the majority of the participants in the study were 
once prescribed an opioid from a primary care provider (2008).   
In those individuals experiencing chronic pain, two distinct characteristics were 
found to be risk factors associated with prescription drug misuse.  More specifically, 
individuals who were found to have a psychological disorder and/or previous substance 
abuse or dependence were more likely to misuse prescription opioids.  That is to say, co-
occurring disorders were more likely to be a contributing factor to individuals who were 




misusing prescription opioids.  In addition, individuals who use illicit drugs at a younger 
age tend to be more susceptible to prescription drug misuse.           
Although there are certain characteristics that provided evidence for medical 
professionals as potential risk factors associated with prescription opioid misuse, research 
suggests that lack of training for primary care providers may also contribute.  On the 
other hand, when primary care providers were afforded the opportunity to participate in a 
structured program, findings yielded positive results.  In addition, it appeared that those 
studies that utilized a multidisciplinary team tended to see better results in the decrease of 
aberrant behaviors associated with prescription opioid misuse.     
Research has shown several screening instruments to aide medical professionals 
when providing an adequate evaluation in determining pharmacological treatment 
appropriateness for consumers with chronic pain.  The PMQ, POMI, and the SOAPP are 
instruments that have been proven to be efficient and effective when assessing 
individuals prior to opioid recommendation for potential risk factors associated with 
prescription opioid misuse.  Perhaps the most time efficient instrument is the PODS 
system, which involves little effort on behalf of the primary care provider.  Unlike the 
previously mentioned screening instruments, the COMM assesses the consumer’s current 
behaviors and can be valuable throughout the ongoing process of long-term opioid 
therapy.   
Not only should medical professionals utilize the existing screening instruments 
that have been found to be reliable and valid, but one must also consider monitoring 
throughout the consumer’s long-term opioid therapy process.  The PMP was created as a 
means to provide access of prescription opioid misuse to healthcare providers; however, 




Katz et al. suggested that majority of the PMP did not implement an effective system in 
exchanging the data (2008).  On the other hand, if PMP is utilized, it is found to have 
assisted in evaluating for some aberrant behaviors.  Additionally, the risk management 
program RADARS could yield beneficial upon determining appropriate interventions, in 
specific geographical regions.   
Implications 
Although much attention has been given to prescription opioid misuse in recent 
years, there appears to be a lack of research conducted on PWD in the literature (Brucker, 
2008).  More specifically, there appears to be an absence of information in assisting 
primary care providers in how to treat co-occurring disorders.  In other words, primary 
care providers have a predicament when it comes to determining appropriate treatment 
modalities for individuals experiencing chronic pain with co-occurring psychological 
and/or substance use disorders, due to the associated characteristics for prescription 
opioid misuse (Jamison et al., 2010).  Co-occurring disorders are seen to be most 
effectively treated simultaneously, yet a further evaluation into the treatment of chronic 
pain, SUDs, and psychological disorders may assist primary care providers in the 
direction of the most effective and efficient treatment for individuals with co-occurring 
disorders.   
Additionally, there still appears to be a lack of training guidelines for primary care 
providers when determining appropriateness for pharmacological treatment in pain 
management.  More or less, the fact still remains that both the primary care provider and 
the consumer need to become educate on the abuse and dependence potentials that can 
accompany the use of prescription opioids.  In the future, research will need to guide 




primary care providers in a direction that measures how effective implementing the use 
of screening assessments and monitoring programs are in decreasing aberrant drug-
seeking behaviors in individuals on long-term opioid therapy.     
Recommendations 
The literature suggests that there has been a shift from individuals with chronic 
pain receiving treatment from a pain management specialist, to a primary care provider.  
In fact, many of the studies indicated that guidance from pain and addiction specialists 
provided resourceful in gather adequate knowledge in addressing the problem of 
prescription opioids.  Thus the responsibility of tackling prescription opioid misuse 
should be viewed from a multidisciplinary team approach (Naliboff, Wu, & Pham, 2006).  
In other words, this vast growing problem should be regarded by all medical professional 
providing comprehensive services to individuals with chronic pain, not primary care 
providers alone.  The research has shown that screening instruments are useful tools 
when detecting potential misuse; however, screening instruments by themselves will not 
unravel the problem.  These instruments should be utilized prior to determining 
pharmacological treatment, while also educating consumers on potential detrimental 
effects of prescription opioid misuse.  
Several studies suggested the importance of employment in individuals 
experiencing chronic pain, not only to optimize quality of life, but because of the risk 
factors associated with unemployment and prescription opioid misuse.  Moreover, it is 
critical for Rehabilitation Counselor to be aware of the impact prescription opioid misuse 
has on potential consumers with chronic pain.  In addition, it is important to note that 
those employed in the blue collar industries or those that work in any manual labor 




position tend to experience chronic pain more frequently than those in a sedentary 
position (Inciardi & Cicero, 2009).  Rehabilitation Counselors may be administering 
vocational evaluations on consumers when exploring alternate employment opportunities.  
Thus, Rehabilitation Counselors must take an active role as part of the multidisciplinary 
team in screening individuals for prescription opioid misuse.  As vocation being a 
primary goal for the role of the Rehabilitation Counselor, it is critical for employment 
purposes that issues of prescription opioid misuse are not involved, yet if in fact it is the 
case, helping consumers find the necessary resources available should be a priority in the 
rehabilitation plan (Brucker, 2008).           
As research suggests, co-occurring disabilities appear to be more prevalent in 
individuals with chronic pain because of the physiological, psychological, and societal 
affects.  Furthermore, as Rehabilitation Counselor working closely with persons with 
disabilities, it is vital that the counselor utilized available resources while also 
concurrently providing the necessary services to the consumer.        
Conclusion 
Based on the evidence gathered, it is imperative that medical professionals 
become aware of the potential risk factors associated with prescription opioid misuse in 
individuals seeking long-term opioid therapy for chronic pain, while utilizing valid 
screening instruments along with monitoring programs.  Moreover, the problem of 
prescription opioid misuse needs to be address from a multidimensional team approach, 
while also advocating for the need to train medical professionals.  DuPont best described 
the notion that prescription opioid misuse “will require significant changes in strategy in 




medical practice, drug development, law enforcement, and public education” (2010; El-
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